Tuesday, February 25, 2020

USFDA issues warning letter to Cipla for Goa manufacturing facility

USFDA issues warning letter to Cipla for Goa manufacturing facility The company further said that it remains committed to maintaining the highest standards of compliance and will work closely with the agency to comprehensively address all the observations

from Moneycontrol Business News https://ift.tt/2wNZJKI

No comments:

Post a Comment

Small and midcap stocks may face volatility, but long-term returns still strong: Vikas Khemani

​Every day there was some negative news flow, global concern, geopolitical concern, inflation concern, oil prices, commodity, everything was...